Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Dec 2021 for Avalo Therapeutics, Inc., €8,857. Read the official filing
Filing timeline
BuySaleH. Jeffrey Wilkins
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
H. Jeffrey Wilkins: trading record in brief
H. Jeffrey Wilkins is a declared insider of Avalo Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 10 June 2021 to 10 December 2021.
The open-market record is one-sided, with 2 purchases worth €11k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 14 December 2021, the filings show an open-market purchase worth €8,857 in Avalo Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to H. Jeffrey Wilkins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6,371 shares@ US$1.57100.0% of flowCommon StockSEC:0001879785-21-000041:0
Canonical exit: 10 Mar 2022 (T+90)
912 shares@ US$2.28100.0% of flowCommon StockSEC:0001192482-21-000498:0
Canonical exit: 8 Sept 2021 (T+90)
2 of 2 declarations
